课题基金 / 基金详情

Development of a Diversity-Oriented Synthesis Platform

Development of a Diversity-Oriented Synthesis Platform
面向多样性的合成平台的开发
批准号:
LP0562615
负责人:
Prof Peter Scammells
金额:
$15.77万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-12-06 至 2008-12-31

项目摘要

项目成果

Prof Peter Scammells的其他基金

相似基金

相关文献

中文摘要
翻译
基因组学、蛋白质组学和其他疾病分子基础的研究为药物发现提供了源源不断的生物分子靶点。确定影响这些目标的合适候选药物的中心是采购合适的化合物库进行筛选。本申请解决了与开发用于此类筛选程序的适当化合物库相关的一些关键问题。
英文摘要
Genomic, proteomic and other studies of the molecular basis of disease are providing a constant stream of biomolecular targets for drug discovery. Identifying suitable drugs candidates to affect these targets centres around procuring a suitable library of compounds for screening. This application addresses some of the key issues related to the development of appropriate compound libraries for such screening programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical-biology approaches to pathway selective adenosine receptor ligands
  • 批准号:
    DP190101945
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $31.61万
  • 财政年份:
    2019
  • 负责人:
    Prof Peter Scammells
  • 依托单位:
Allosteric and Bitopic Ligands Acting at G Protein-Coupled Receptors
  • 批准号:
    DP160101970
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $46.82万
  • 财政年份:
    2016
  • 负责人:
    Prof Peter Scammells
  • 依托单位:
New methodology for the manufacture of opioid pharmaceuticals and the discovery of novel opiate receptor ligands
  • 批准号:
    LP110200377
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $15.04万
  • 财政年份:
    2012
  • 负责人:
    Prof Peter Scammells
  • 依托单位:
Understanding allosteric modulation and functional selectivity at G Protein-Coupled Receptors (GPCRs)
  • 批准号:
    DP110100687
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.56万
  • 财政年份:
    2012
  • 负责人:
    Prof Peter Scammells
  • 依托单位:
海外基金